Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice

被引:3
|
作者
Shamsuzzaman, Sohel [1 ]
Onal, Melda [1 ]
St John, Hillary C. [1 ]
Pike, J. Wesley [1 ]
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
关键词
RANKL; DISTAL ENHANCER; ATHEROSCLEROTIC PLAQUE; mu CT; PLAQUE CALCIFICATION; GENE REGULATION; PLAQUE RANKL; KAPPA-B LIGAND; SMOOTH-MUSCLE-CELLS; OSTEOCLAST DIFFERENTIATION FACTOR; TISSUE-SPECIFIC EXPRESSION; VITAMIN-D-RECEPTOR; VASCULAR CALCIFICATION; ARTERIAL CALCIFICATION; BONE LOSS; TNFSF11; GENE; T-CELLS;
D O I
10.1002/jcb.26074
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Receptor activator of NF-B ligand (RANKL) is a TNF-like cytokine which mediates diverse physiological functions including bone remodeling and immune regulation. RANKL has been identified in atherosclerotic lesions; however, its role in atherosclerotic plaque development remains elusive. An enhancer located 75kb upstream of the murine Rankl gene's transcription start site designated D5 is important for its calciotropic hormone- and cytokine-mediated expression. Here, we determined the impact of RANKL levels in atherosclerotic plaque development in the D5 enhancer-null (D5(-/-)) mice in an atherogenic Apoe(-/-) background fed a high-fat diet (HFD). Rankl mRNA transcripts were increased in aortic arches and thoracic aortae of Apoe(-/-) mice; however, this increase was blunted in Apoe(-/-);D5(-/-) mice. Similarly, higher Rankl transcripts were identified in splenic T lymphocytes in Apoe(-/-) mice, and their levels were reduced in Apoe(-/-);D5(-/-) mice. When analyzed by micro-computed tomography (mu CT), atherosclerotic plaque calcification was identified in six out of eight Apoe(-/-) mice, whereas only one out of eight Apoe(-/-);D5(-/-) mice developed plaque calcification after 12 weeks of HFD. However, following 18 weeks of HFD challenge, all of Apoe(-/-) and Apoe(-/-);D5(-/-) animals developed atherosclerotic plaque calcification. Likewise, atherosclerotic lesion sizes were site-specifically reduced in the aortic arch of Apoe(-/-);D5(-/-) mice at initial stage of atherosclerosis and this effect was diminished as atherosclerosis proceeded to a more advanced stage. Our data suggest that deletion of the RANKL D5 enhancer delays the progression of atherosclerotic plaque development and plaque calcification in hypercholesterolemic mice. This work provides important insight into RANKL's regulatory role in atherosclerosis. J. Cell. Biochem. 118: 4240-4253, 2017. (c) 2017 Wiley Periodicals, Inc.
引用
收藏
页码:4240 / 4253
页数:14
相关论文
共 50 条
  • [1] Absence of the Vitamin D Receptor Inhibits Atherosclerotic Plaque Calcification in Female Hypercholesterolemic Mice
    Shamsuzzaman, Sohel
    Onal, Melda
    St John, Hillary C.
    Jeffery, Justin J.
    Pike, John W.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (05) : 1050 - 1064
  • [2] Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice
    Oh, Yun K.
    Bachar, Adi R.
    Zacharias, David G.
    Kim, Sung Gyun
    Wan, Junxiang
    Cobb, Laura J.
    Lerman, Lilach O.
    Cohen, Pinchas
    Lerman, Amir
    ATHEROSCLEROSIS, 2011, 219 (01) : 65 - 73
  • [3] The immune response is involved in atherosclerotic plaque calcification: Could the RANKL/RANK/OPG system be a marker of plaque instability?
    Montecucco, Fabrizio
    Steffens, Sabine
    Mach, Francois
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2007, : 75805
  • [4] Association between the progression of aortic valve calcification and coronary atherosclerotic plaque volume
    Lee, S. E.
    Budoff, M. J.
    Conte, E.
    Hadamitzky, M.
    Leipsic, J. A.
    Cademartiri, F.
    Pontone, G.
    Stone, P. H.
    Bax, J. J.
    Narula, J.
    Lin, F. Y.
    Berman, D. S.
    Min, J. K.
    Shaw, L. J.
    Chang, H. J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 183 - 183
  • [5] A Novel Distal Enhancer Mediates Cytokine Induction of Mouse Rankl Gene Expression
    Bishop, Kathleen A.
    Meyer, Mark B.
    Pike, J. Wesley
    MOLECULAR ENDOCRINOLOGY, 2009, 23 (12) : 2095 - 2110
  • [6] Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification
    Purroy, Ana
    Roncal, Carmen
    Orbe, Josune
    Meilhac, Olivier
    Belzunce, Miriam
    Zalba, Guillermo
    Villa-Bellosta, Ricardo
    Andres, Vicente
    Parks, William C.
    Paramo, Jose A.
    Rodriguez, Jose A.
    ATHEROSCLEROSIS, 2018, 278 : 124 - 134
  • [7] Association between Aortic Valve Calcification Progression and Coronary Atherosclerotic Plaque Volume Progression in the PARADIGM Registry
    Lee, Sang-Eun
    Sung, Ji Min
    Andreini, Daniele
    Al-Mallah, Mouaz H.
    Budoff, Matthew J.
    Cademartiri, Filippo
    Chinnaiyan, Kavitha
    Choi, Jung Hyun
    Chun, Eun Ju
    Conte, Edoardo
    Gottlieb, Ilan
    Hadamitzky, Martin
    Kim, Yong Jin
    Lee, Byoung Kwon
    Leipsic, Jonathon A.
    Maffei, Erica
    Marques, Hugo
    Goncalves, Pedro de Araujo
    Pontone, Gianluca
    Shin, Sanghoon
    Stone, Peter H.
    Samady, Habib
    Virmani, Renu
    Narula, Jagat
    Berman, Daniel S.
    Shaw, Leslee J.
    Bax, Jeroen J.
    Lin, Fay Y.
    Min, James K.
    Chang, Hyuk-Jae
    RADIOLOGY, 2021, 300 (01) : 79 - 86
  • [8] Effect of dabigatran etexilate and warfarin on atherosclerotic plaque calcification in ApoE-/- mice
    Schurgers, L. J.
    van Gorp, R.
    Willems, B.
    Spronk, H.
    Reutelingsperger, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 790 - 791
  • [9] Porphyromonas gingivalis enhances atherosclerotic plaque calcification in ApoE+/- mice.
    Geva, MS
    Liu, Y
    Champagne, CME
    Southerland, JH
    Madianos, PN
    Offenbacher, S
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 516 - 516
  • [10] Oral rapamycin attenuates progression of atherosclerotic plaque in ApoE knockout mice
    Pakala, R
    Burnett, MS
    Gulick, CP
    Fournadjiev, J
    Leborgne, L
    Cheneau, EF
    Hellinga, D
    Epstein, SE
    Waksman, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 239A - 239A